MEIP icon

MEI Pharma
MEIP

Overview Fund Activity

71 hedge funds and large institutions have $62M invested in MEI Pharma in 2019 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 17 increasing their positions, 26 reducing their positions, and 11 closing their positions.

Holders
71
Holders Change
-2
Holders Change %
-2.74%
% of All Funds
1.56%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
9
Increased
17
Reduced
26
Closed
11
Calls
$1.06M
Puts
$1.03M
Net Calls
+$29K
Net Calls Change
+$80K

Top Buyers

1
Northern Trust
1
Northern Trust
Illinois
$1.21M
2
WG
2
Winton Group
United Kingdom
$732K
3
WA
3
Wasatch Advisors
Utah
$2.8M
4
Renaissance Technologies
4
Renaissance Technologies
New York
$4.78M
5
HSBC Holdings
5
HSBC Holdings
United Kingdom
$389K

Top Sellers

1
VC
1
Vivo Capital
California
$0
2
Assenagon Asset Management
2
Assenagon Asset Management
Luxembourg
$0
3
CC
3
Caxton Corporation
New Jersey
$1.42M
4
SCM
4
Sio Capital Management
New York
$435K
5
FI
5
Fosun International
China
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
HF
76
HRT Financial
New York
– -$126K -2,522 Closed
SAM
77
Sectoral Asset Management
Quebec, Canada
– -$111K -2,227 Closed
LI
78
Leap Investments
Illinois
– -$86K -1,720 Closed
CSS
79
Cubist Systematic Strategies
Connecticut
– -$46K -913 Closed
VF
80
Virtu Financial
New York
– -$32K -640 Closed
1 2 3
4